Analytical Review of Concord Biotech Limited IPO
Concord Biotech Limited is an India-based biopharma company that develops and manufactures active pharmaceutical ingredients (APIs). The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022. Concord Biotech is offering an initial public offering (IPO) of […]